1. Background {#sec153037}
=============

Hepatitis C virus (HCV) is the most common cause of chronic liver disease and also an important factor in liver transplantation (CDC, www.cdc.gov/hepatitis/hcv/hcvfaq.htm). The world health organization (WHO) has estimated that 3% of the world's population has been infected with hepatitis C virus (HCV) and currently more than 170 million carry chronic HCV (WHO, www.who.int). HCV is considered the cause of approximately one-third of HCC cases in the USA. According to various reports, it is estimated that the risk of development of HCC when liver cirrhosis has progressed is 0 to 3% per year. The risk of HCC in chronic infections of HCV is highly associated with fibrosis stage. The incidence of HCC is relatively high in patients with cirrhosis (1% - 7% per year) ([@A36005R1], [@A36005R2]).

Experimental observations have shown that HCV viral proteins interact with cell proliferation and survival pathways, which lead to the increased risk of HCC. The over-expression of HCV protein enhances cell proliferation, transformation, and tumor development in mice, which suggests that viral proteins lead to the activation of oncogenic pathways ([@A36005R3]). Several studies have shown that core protein can participate in liver cancer caused by HCV. It has been shown that the core protein expression can modulate cellular mRNA transcription through the interaction with hnRNP K ([@A36005R4]). It also has been shown that the core protein can affect p53 protein through various mechanisms such as physical connection ([@A36005R5], [@A36005R6]). Studies have suggested that non-structural HCV proteins may also play a role in carcinogenesis ([@A36005R7]). In parallel with this hypothesis, it has been reported that the expression of three HCV genes, including *NS3*, *NS5A* and *NS5B* can affect cell proliferation. *NS3* and *NS5A* proteins can inhibit transcription of *p21* ([@A36005R8]-[@A36005R10]) and *NS5A* protein impairs the cell cycle pathway by targeting *cdk1/2*-cyclin complex ([@A36005R11]). *NS5A* protein also activates the Wnt pathway and stimulates the β-catenin-responsive transcription by activating the phosphoinositide 3-kinase ([@A36005R12]). Finally, expression of non-structural *NS5B* protein, by targeting proteasomal degradation of pRB, leads to up-regulation of *E2F*-responsive promoter and induction of cell entry into the S phase of the cell cycle ([@A36005R13]).

Although the molecular mechanisms of HCV-induced HCC remain to be discovered, studies have suggested that HCV is the important factor in providing an appropriate microenvironment for progression and development of cancer ([@A36005R14]). In addition, gene expression alterations of chronic liver disease and molecular mechanisms involved in the HCV-induced HCC are not well understood.

2. Objectives {#sec153038}
=============

Nowadays, the network-based analysis of high-throughput gene expression profiles is emerging as a reliable tool in the perception of biological processes. In the present study, we studied the possible role of HCV in HCC initiation and invasion using topological analysis of PPI networks.

3. Materials and Methods {#sec153044}
========================

3.1. Microarray Data {#sec153039}
--------------------

The gene expression profile GSE38226 was obtained from the public functional genomics data repository gene expression omnibus (GEO) database (www.ncbi.nlm.nih.gov/geo/). There are two Illumina platforms in this transcription profile, including GPL6947 and GPL8179 used as mRNA and miRNA expression beadchips, respectively. Before the mRNA and miRNA expression profiling, the liver biopsies were collected from chronic HCV patients (24 samples), patients with hepatocellular carcinoma (12 samples) and normal subjects (8 samples). The samples were used to identify the differentially expressed genes (DEGs) and differentially expressed miRNAs (DEMs) using GEO2R ([@A36005R15]).

3.2. Functional Annotation of DEGs and DEMs {#sec153040}
-------------------------------------------

Gene ontology (GO) annotation of all DEGs was performed using g: Profiler public web server (http://biit.cs.ut.ee/gprofiler/). g: Profiler is a powerful web tool for characterizing and manipulating the gene lists obtained from analysis of the high-throughput genomic data. The overrepresented GO terms with significant P value filtered from the primary results.

To determine functional categories of DEMs obtained from the previous step, the list of DEMs of both chronic HCV and HCC expression profiles were introduced to the TAM tool ([@A36005R16]). The list of DEMs was functionally annotated and summarized according to the integrated miRNA categorical data. The important functional categories were chosen for further analysis. There was a considerable overlap between the enrichment results of chronic HCV and HCC in the given DEMs lists.

3.3. Protein-Protein Interaction (PPI) Network Construction {#sec153041}
-----------------------------------------------------------

Based on the STRING (a protein-protein interaction database) ([@A36005R17]) and GenMANIA (a web service used for prediction of gene function) regulation databases, we constructed and visualized the corresponding PPI networks using Cytoscape software ([@A36005R18]). We considered directed interactions as well as important undirected interactions such as genetic interactions for building PPI networks. The number of nodes-edges in the PPI networks constructed from chronic HCV and HCC gene expression profiles were 171 - 1090 and 175 - 1161, respectively.

3.4. Topological Analysis of PPI Networks {#sec153042}
-----------------------------------------

Topological network analysis was performed for PPI networks and the most important hub genes were identified. The network analyzer plugin of cytoscape was used to analyze topological properties of the networks. Among nine evaluated methods, degree, betweenness centrality and closeness centrality had better outcomes and used for topological analysis of the PPI networks. Degree measure refers to the number of neighbors (edges) of a node and the nodes with higher degree centrality are considered biologically important hub genes within biological networks. Betweenness centrality is another centrality measure that represents the number of times each node is visited during traversing all shortest paths and is computed as follows:
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The s and t are nodes in the network different from n, σ~st~ indicates the number of shortest paths from s to t and σ~st~ (n) is the number of shortest paths from s to t that n lies on.

The closeness centrality of a node is a measure of how fast information spreads from a given node to other reachable nodes in the given network. This measure is computed as follows:
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Where L (n, m) is the length of the shortest path between two n and m nodes. The closeness centrality of each node is a number between 0 and 1.

We selected the top 50 genes according to the ranked results of three mentioned methods. Furthermore, the putative miRNAs regulating hub genes were predicted *in silico*using mirTarBase server ([@A36005R19]) and a new miRNA-Hubgene network was reconstructed for both chronic HCV and HCC gene expression profiles. Topological analysis of the new miRNA-Hubgene networks was also performed using the degree measure to identify the hub miRNAs in each network. Interestingly, most hub miRNAs had been determined as DEMs after miRNA expression analysis of chronic HCV and HCC samples with GEO2R.

3.5. PPI Networks Alignment {#sec153043}
---------------------------

A network alignment allows us to find the conserved functional complexes between two or more given networks. The alignment between chronic HCV and HCC networks was performed by NETAL tool ([@A36005R20]). The NETAL is a new method for global alignment of PPI networks based on both biological and topological information of input networks. This method is highly capable of finding the conserved functional complexes and evolutionary relationships. The edge correctness (EC) measure was considered an important parameter to determine topological similarity between chronic HCV and HCC derived PPI networks. EC is the percentage of interactions aligned between the given networks. After comparative analysis of chronic HCV and HCC networks, the most important common sub-network was determined and visualized.

4. Results {#sec153048}
==========

4.1. Functional Annotation Analysis {#sec153045}
-----------------------------------

Analysis of the functional annotation of chronic HCV and HCC related DEGs specifically indicated that most genes, in both chronic HCV and HCC related DEGs, are involved in important cellular processes such as cell signaling, cell proliferation, cell death, cell migration, etc. ([Table 1](#tbl39060){ref-type="table"}). These functional categories are obviously involved in the cancer progression and invasion.

###### Overrepresented gProfiler Terms in the DEGs From HCC and Chronic HCV

  DEGs Source            Number of Genes   P Value
  ---------------------- ----------------- ------------
  **HCC**                                  
  Localization           85                1.58e - 03
  Signaling              87                2.68e - 02
  Cell proliferation     38                2.39e - 02
  Cell death             37                3.14e - 02
  Cell migration         36                5.18e - 06
  Extracellular matrix   75                3.15e - 04
  **Chronic HCV**                          
  Signaling              101               1.66e - 07
  Localization           81                2.12e - 02
  Cell adhesion          56                3.19e - 17
  Immune response        59                3.68e - 08
  Cell death             40                7.57e - 03
  Angiogenesis           21                1.05e- 06

Furthermore, we enriched the list of DEMs obtained from miRNA expression analysis of both HCC and chronic HCV samples. Interestingly, there was a considerable overlap between the functional categories of chronic HCV and HCC related DEMs ([Figure 1](#fig28842){ref-type="fig"}). Similarly to DEGs, a high number of miRNAs predicted as regulators of several cancer-related pathways such as cell cycle, cell proliferation, cell death, apoptosis, epithelial-mesenchymal transition and angiogenesis. We found that the four important onco-miRNA (*hsa-miR-24*, *hsa-miR-92a*, *hsa-miR-194* and *hsa-miR-191*) were up-regulated in both chronic HCV and HCC samples compared to the control liver cells. Furthermore, several miRNA tumor suppressors, including *hsa-miR-181b*, *hsa-miR-451*, *hsa-miR-34a*, *hsa-miR-34b* and *hsa-miR-34c* were significantly down-regulated in chronic HCV and HCC samples compared to the control samples.

![Functional Enrichment Analysis of DEMs Resulted From miRNA Expression Analysis of Chronic HCV and HCC Samples](hepatmon-16-02-36005-i001){#fig28842}

4.2. Topological Analysis of PPI Networks {#sec153046}
-----------------------------------------

The PPI networks for DEGs resulted from analysis of chronic HCV and HCC gene expression profiles were constructed with 171 - 1090 and 175 - 1161 nodes-edges, respectively. We used the degree, betweenness centrality and closeness centrality measures to analyze topology of resulted PPI networks. The top 50 hub genes of these three measures were selected for further analysis ([Tables 2](#tbl39061){ref-type="table"} and [3](#tbl39062){ref-type="table"}). After filtering and removing duplicate values, we obtained 61 and 64 unique hub genes from the topological analysis of chronic HCV and HCC related PPIs, respectively. There were 32 common hub genes between chronic HCV and HCC unique hub genes. Interestingly, the c-Jun gene was identified as the most important hub gene in both chronic HCV and HCC related PPI networks. In parallel, validated corresponding miRNAs for each hub gene were determined and a new miRNAs-Hubgenes network was reconstructed with 217 and 319 nodes and edges, respectively. Topological analysis of miRNAs-Hubgenes regulatory network was performed and the hub miRNAs were identified and visualized along with their putative targets ([Figure 2](#fig28843){ref-type="fig"}). We compared the hub miRNAs with DEMs obtained from the miRNA expression profile of chronic HCV and HCC samples. The comparison indicated a positive correlation between chronic HCV and HCC resulted DEMs. Two hub miRNAs, including *hsa-miR-34a* and *hsa-miR-155* were significantly down-regulated in both chronic HCV and HCC samples compared to normal liver samples. Moreover, three other hub miRNAs (*hsa-miR-24*, *hsa-miR-744* and *hsa-miR-92a*) were up-regulated in chronic HCV and HCC samples compared to the control samples.

###### The Top 50 Hub Genes Obtained From Analysis of the Chronic HCV Network

  Betweenness    Value      Degree     Value   Closeness   Value
  -------------- ---------- ---------- ------- ----------- ----------
  **JUN**        0.088456   JUN        60      JUN         0.563107
  **KCNMA1**     0.045263   KCNMA1     38      KCNMA1      0.537037
  **SLC1A1**     0.044697   COL4A1     36      SLC1A1      0.52568
  **BCL2**       0.035565   SLC1A1     35      LEF1        0.517857
  **COL4A1**     0.035263   LEF1       33      COL4A1      0.514793
  **PODXL**      0.031336   BCL2       32      ACACB       0.513274
  **BIRC3**      0.030732   VEGFC      31      ENAH        0.511765
  **VEGFC**      0.029737   COL1A2     31      BCL2        0.508772
  **WNT4**       0.029547   BIRC3      30      VEGFC       0.507289
  **ENAH**       0.02707    ENAH       30      COL1A2      0.501441
  **POLQ**       0.026244   SOX9       29      PID1        0.501441
  **ACACB**      0.025908   COL5A1     29      PODXL       0.5
  **LEF1**       0.025767   COL15A1    29      WNT4        0.5
  **CELF4**      0.024233   PODXL      28      BIRC3       0.498567
  **FANCC**      0.022376   WNT4       28      COL15A1     0.497143
  **SLCO3A1**    0.022328   ACACB      28      CELF4       0.494318
  **TSPAN8**     0.021671   SLCO3A1    28      SLCO3A1     0.492918
  **SMOC2**      0.020669   MYOF       28      CD34        0.492918
  **SOX9**       0.020065   TSPAN8     27      BCAS4       0.491525
  **TMEM200A**   0.019163   SOX4       26      MYOF        0.490141
  **SOX4**       0.01913    BCAS4      26      TSPAN8      0.490141
  **STK39**      0.018437   THBS2      26      AGTRAP      0.490141
  **COL5A1**     0.017963   CD44       26      BRCA1       0.488764
  **CBLN1**      0.017321   CELF4      25      KCNN2       0.487395
  **ADCY1**      0.016641   PID1       25      SOX9        0.486034
  **OSBPL3**     0.016441   COL4A2     25      SOX4        0.486034
  **BCAS4**      0.01626    ADRA1A     24      SPP1        0.486034
  **MYOF**       0.015722   CD34       24      STK39       0.483333
  **COL1A2**     0.014797   STK39      23      COL5A1      0.481994
  **THBS2**      0.014385   BRCA1      23      PDGFRB      0.481994
  **CCL20**      0.014217   SPP1       23      FRZB        0.481994
  **TGFBI**      0.014096   CHRM3      23      CHRM3       0.480663
  **FRZB**       0.014042   KCNN2      23      SMOC2       0.480663
  **COL15A1**    0.014024   POLQ       22      CBLN1       0.480663
  **CD44**       0.013973   FANCC      22      ERBB2       0.479339
  **FST**        0.013728   SMOC2      22      THBS2       0.476712
  **STAG3**      0.01337    TMEM200A   22      ADRA1A      0.476712
  **S100A13**    0.013157   CBLN1      22      POLQ        0.476712
  **ACSL1**      0.012823   TGFBI      22      VWF         0.476712
  **DACT2**      0.012597   ST3GAL6    22      PARM1       0.476712
  **BRCA1**      0.01237    COL1A1     22      NOS1AP      0.476712
  **RRM2**       0.012267   OSBPL3     21      ST3GAL6     0.47541
  **ADRA1A**     0.012258   PDGFRB     21      COL1A1      0.47541
  **PLVAP**      0.011888   B3GALNT1   20      CMIP        0.47541
  **SPP1**       0.011585   ERBB2      20      TGFBI       0.472826
  **B3GALNT1**   0.011486   AGTRAP     20      TMEM200A    0.471545
  **SFRP5**      0.011395   ADCY1      19      ASPH        0.47027
  **CHRM3**      0.011097   STAG3      19      CD44        0.469003
  **KCNN2**      0.01109    DCDC2      19      SERPINE2    0.469003
  **PID1**       0.011078   VWF        19      COL4A2      0.467742

###### The Top 50 Hub Genes Obtained From Analysis of the HCC Network

  Betweenness    Value      Degree     Value   Closeness   Value
  -------------- ---------- ---------- ------- ----------- ----------
  **JUN**        0.152054   JUN        79      JUN         0.602837
  **PAPPA**      0.064493   BCL2       39      BCL2        0.532915
  **BCL2**       0.04056    KCNMA1     36      COL1A2      0.519878
  **KCNMA1**     0.040488   COL1A2     36      PAPPA       0.519878
  **VEGFC**      0.038859   PAPPA      35      VEGFC       0.519878
  **PDGFD**      0.037164   SOX9       33      KCNMA1      0.516717
  **COL4A1**     0.033355   COL4A1     32      COL4A1      0.515152
  **ERBB2**      0.033017   CD44       32      ERBB2       0.515152
  **COL1A2**     0.031187   EGR1       32      SOX9        0.505952
  **SOX9**       0.029953   VEGFC      31      EGR1        0.505952
  **IL8**        0.028423   ERBB2      29      FMOD        0.504451
  **CCR6**       0.02778    IL8        28      SOD3        0.501475
  **FMOD**       0.024919   FMOD       27      PODXL       0.5
  **PODXL**      0.023075   PODXL      27      CD34        0.5
  **CD44**       0.022533   WNT4       27      PDGFRB      0.5
  **EGR1**       0.021941   IL6        27      CD44        0.498534
  **MOXD1**      0.02144    COL5A1     27      WNT4        0.498534
  **SPP1**       0.020341   MOXD1      26      SPP1        0.498534
  **CD34**       0.019815   CD34       26      IL8         0.497076
  **PDLIM3**     0.018409   SPP1       25      COL1A1      0.497076
  **WNT4**       0.017109   COL4A2     25      MOXD1       0.494186
  **SLCO3A1**    0.017079   COL15A1    25      IL6         0.492754
  **IL6**        0.016092   COL1A1     24      UCHL1       0.489914
  **TGFBI**      0.015425   SLCO3A1    23      FRZB        0.489914
  **LYVE1**      0.015167   SOD3       23      VWF         0.487106
  **HDC**        0.014886   PDGFRB     23      COL5A1      0.48433
  **SOD3**       0.014787   COL6A3     23      SLCO3A1     0.482955
  **MYOF**       0.014711   PDGFD      22      AGTRAP      0.481586
  **PTGS2**      0.014547   MYOF       22      PID1        0.478873
  **SMOC2**      0.014195   TGFBI      21      PTGS2       0.478873
  **COL4A2**     0.013321   SMOC2      21      COL6A3      0.477528
  **UCHL1**      0.013228   UCHL1      21      COL3A1      0.477528
  **COL1A1**     0.013075   VWF        21      COL4A2      0.47619
  **VWF**        0.01304    PID1       21      TGFBI       0.47619
  **COL5A1**     0.013023   FRZB       21      SMOC2       0.47619
  **CBLN1**      0.012941   HDC        20      SGCD        0.47619
  **PID1**       0.012849   PTGS2      20      NAB2        0.47619
  **MYL9**       0.012038   CCR6       19      BRCA1       0.47486
  **FAP**        0.011566   SGCD       19      CBLN1       0.47486
  **FRZB**       0.011414   NAB2       19      COL15A1     0.473538
  **ENO2**       0.010941   COL3A1     19      MYOF        0.473538
  **TMEM200A**   0.01088    TMEM200A   18      HDC         0.472222
  **SGCD**       0.009918   BRCA1      18      CMIP        0.470914
  **CD3E**       0.009637   FOSB       17      ACTA2       0.469613
  **PDGFRB**     0.009418   THBS2      17      PDGFD       0.467033
  **COL15A1**    0.00936    PDLIM3     16      CCR6        0.465753
  **PLAT**       0.009294   CBLN1      16      DPYSL3      0.465753
  **FBLN1**      0.009258   FAP        16      FOSB        0.464481
  **BRCA1**      0.008361   CD3E       16      SERPINE2    0.464481
  **CLEC2B**     0.008261   SAA1       16      PLAT        0.464481

![The Regulatory Network of Hub miRNAs (Dark Green Hexagons) Along With Hub Genes of Chronic HCV (Red Circles) and HCC (Pale Green Circles) PPI Networks\
Nodes with higher degrees are shown in the bigger circles. The common hub genes between chronic HCV and HCC are shown with dark cyan circles.](hepatmon-16-02-36005-i002){#fig28843}

4.3. PPI Networks Alignment {#sec153047}
---------------------------

After networks alignment, several sub-networks were identified as common complexes between chronic HCV and HCC networks. The EC measure was equal to 0.45 indicating approximately 45% of topological similarity between the given networks. The connected component between the two PPI networks had 156 nodes and 471 edges. We selected a 22-node sub-network as the most important functional complex, which consists of 13 common genes with positive correlation ([Figure 3](#fig28844){ref-type="fig"}). The functional annotation analysis demonstrated that this sub-network is actively involved in regulation of cell proliferation, cell migration and apoptosis.

![The Most Important Functional Sub-Network Obtained From Two PPI Network Alignments\
The common genes between chronic HCV and HCC networks are shown in the green color boxes. The red and yellow boxes represent chronic HCV and HCC specific genes, respectively.](hepatmon-16-02-36005-i003){#fig28844}

5. Discussion {#sec153050}
=============

Strong epidemiological evidence links hepatitis C infection with hepatocellular carcinoma ([@A36005R3]). Liver cancer usually develops decades after HCV infection and liver cirrhosis. However, the molecular mechanisms involved in cancer development have not been fully understood. HCV is classified as a positive-strand RNA virus that replicates in the cytoplasm and does not integrate into the host DNA; however, its carcinogenic features are remarkable. It is possible that indirect mechanisms such as chronic liver inflammation, oxidative damages, presence of cirrhosis and DNA damage are involved in cancer development ([@A36005R21], [@A36005R22]). Cirrhosis as the result of fibrosis due to hepatitis C infection is the indication of preneoplastic stage in development of liver cancer, which can cause rapid proliferation of dysplastic liver cells ([@A36005R21]). Studies have shown that HCV proteins, especially core protein, are inherently oncogenic and their expression in the cell can be involved in the development of HCC directly and in the absence of immune responses or cirrhosis. Several HCV proteins can interact with host cell proteins and induce cell proliferation. Evidence has shown that replication of HCV replicon RNAs is strongly dependent on cell proliferation ([@A36005R23]), while the HCV RNA synthesis is stimulated in the S phase of the cell cycle ([@A36005R24]). Hepatocytes usually have low proliferation rate and it seems that some viral proteins expressed during HCV infection trigger cell division and are involved in carcinogenic effects of chronic HCV infection ([@A36005R22], [@A36005R25]).

A positive correlation between chronic HCV infection and HCC progression has been frequently reported. However, the main mechanisms underlying pathogenesis of HCV-induced HCC has remained unclear. We reported here molecular mechanisms regulated by HCV, which seem to be involved in HCC progression and invasion. We found that the *c-Jun* gene is the most important hub gene obtained from topological analysis of both HCV and HCC networks. The *c-Jun* has a key role in enhanced cell proliferation of cancer cells by regulating the expression of *CCND1* and *Cdc2* genes ([@A36005R26]). In addition, *c‐Jun* can prevent *TNFα*-mediated apoptosis through cooperation with *NFKB1*. Erhadt and colleagues reported that HCV can protect various cells from *TNFα*-induced apoptosis via activating *NFKB* signaling pathway ([@A36005R27]). Taken together, we suggest that the role of HCV in the inhibition of apoptosis is mediated by c‐Jun function. Two proto-oncogene, *BCL2* and *ERBB2*, were identified as the common hub genes of HCV and HCC-derived PPI networks. The *BCL2* overexpressing cells tend to have a prolonged survival and reduced apoptosis in a variety of cancer cells. This gene is highly capable of suppressing apoptosis by either inhibiting the release of cytochrome c from the mitochondria or blocking the function of *APAF1* ([@A36005R28]). It is now well established that HCV triggers cancer cell apoptosis and survival through up-regulation of *BCL2* expression, resulting in reduced *CASP3* activity. The nonstructural protein 4B (*NS4B*) is the key gene responsible for stimulating *BCL2* gene through inhibition of the function of *SOCS3* gene ([@A36005R29]). *ERBB2* is a protein tyrosine kinase that can bind to other growth factor receptors to form a heterodimer, stabilizing ligand-receptor complex and enhancing several downstream signaling pathways such as mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K/Akt1) ([@A36005R10], [@A36005R30]). This gene was identified as an important hub gene in both chronic HCV and HCC networks. The statistically significant correlation between *NS3*, an HCV serine protease, and *ERBB2* has been reported in HCC cases ([@A36005R31]). VEGFC is an important gene involved in promoting angiogenesis. This hub gene was up-regulated in HCV and HCC samples compared to normal liver cells. It is now widely accepted that HCV is of central importance for vascular development and angiogenesis through enhancing the expression of *VEGFC* ([@A36005R32]).

Extracellular matrix proteins play a pivotal role in tumor progression and their alterations are usually associated with an aggressive phenotype of various cancer types. Our results revealed that expression of *COL4A2*, *COL1A1* and *COL5A1* hub genes were significantly altered in the HCV-infected and HCC cells compared to the normal cell samples. These genes are necessary for spreading HCC cells through remodeling of extracellular matrix ([@A36005R33]). Recently, it has been determined that HCV infection can lead to an increased invasive phenotype by regulating the matrix metalloproteinases (MMPs), a family of extracellular matrix components ([@A36005R34]). However, the role of HCV in regulation of collagen genes is poorly understood.

Amongst non-coding RNAs, the role of miRNAs in carcinogenesis has been extensively investigated. Varnholt and colleagues examined the miRNA gene expression profile of HCV-infected HCC cells and identified several important miRNAs that seem to be involved in the pathogenesis of HCV-associated HCC ([@A36005R26]). We found that the miRNA gene expression profile of HCV-infected cells is clearly similar to HCC cells. The *hsa-miR-155* and *hsa-miR-34a* were down-regulated in both HCV-infected and HCC cells compared to the control samples. The HCV core and *NS5A* proteins have been implicated in pathogenesis of HCC through induction of Wnt signaling pathway ([@A36005R28]). HCV-associated activation of Wnt signaling pathway may be mediated by expression alterations of *hsa-miR-34a* and *has-miR-744*. Additionally, the HCV can actively induce cell proliferation and MAPK signaling pathway in vitro ([@A36005R27]). However, the distinct mechanism defining the effect of HCV on the cell proliferation has remained unknown. Here, we show that HCV can positively impair cell cycle progression through inhibition of hsa-miR-34a. The expression of two cell proliferation-related genes, RRM2 and BIRC3, is regulated by *hsa-miR-34a* ([Figure 4](#fig28845){ref-type="fig"}). This miRNA can activate the MAPK signaling pathway.

![The Hub miRNAs Obtained From Topological Analysis of miRNA-Hubgene Network Along With Their Putative Targets\
Up-regulated and down-regulated hub miRNAs with positive correlation in both HCV-infected and HCC cells are shown in red and green boxes, respectively.](hepatmon-16-02-36005-i004){#fig28845}

However, activation of MAPK, AKT1, NFKB1 and JAK-STAT signaling pathways is also mediated through down-regulation of *hsa-miR-155*. This hub miRNA was significantly down-regulated in both HCV-infected and HCC cells compared to normal cells. However, functional study of *hsa-miR-155* targets revealed that down-regulation of this miRNA can induce cell proliferation and angiogenesis and inhibit apoptosis through activating aforementioned signaling pathways ([Figure 4](#fig28845){ref-type="fig"}). The *hsa-miR-24* acts as an anti-apoptotic miRNA by repressing the expression of *Bim* gene ([@A36005R35]). We found that this hub miRNA was up-regulated in HCV-infected and HCC samples, suggesting its possible effect on the progression of HCC cells. Furthermore, the function of tumor suppressor *BRCA1* is considerably modulated by *hsa-miR-24*. The *hsa-miR-92a* is a key regulator of angiogenesis and apoptosis. It has been shown that overexpression of *hsa-miR-744* can moderately induce tube formation and reduce apoptosis in vitro ([@A36005R36]).

5.1. Conclusion {#sec153049}
---------------

This study indicated that characteristics of invasive phenotype HCC cells are associated with differential expressions of several genes and miRNAs. The graph-based information may give us a new insight into molecular mechanisms underlying the pathogenesis of HCV-induced HCC.
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